Yu Mao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu Mao has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Chengpeng Gu
Robotic Minimally Invasive Surgery Center, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
3 shared publications- Dong Wang
Robotic Minimally Invasive Surgery Center, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
3 shared publications Fei Yang
Robotic Minimally Invasive Surgery Center, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
3 shared publications- Shangqing Ren
Robotic Minimally Invasive Surgery Center, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
3 shared publications Ting Hu
Robotic Minimally Invasive Surgery Center, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
3 shared publicationsXiang Dong
Robotic Minimally Invasive Surgery Center, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
3 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1899751
Prognostic performance of preoperative systemic inflammatory biomarkers in upper tract urothelial carcinoma after radical nephroureterectomy: a systematic review and meta-analysis of NLR, MLR, PLR, SII and SIRI
Background: Risk stratification remains challenging in patients with upper tract urothelial carcinoma (UTUC) undergoing radical nephroureterectomy (RNU). Preoperative systemic inflammatory biomarkers may provide prognostic information, but their relative clinical utility remains unclear. Methods: This systematic review and meta-analysis evaluated five commonly used preoperative inflammatory biomarkers—neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI)—in patients with UTUC treated with RNU. PubMed, Embase, Web of Science, and Cochrane Library were searched up to March 2026. Multivariate hazard ratios (HRs) for overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) were pooled using random-effects models. Evidence certainty was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Results: Twelve retrospective studies comprising 7,346 patients were included. Elevated inflammatory biomarker levels were generally associated with worse survival outcomes across available studies. Significant associations with overall survival were observed for SIRI (pooled HR 2.09, 95% CI 1.27–3.44), NLR (pooled HR 1.97, 95% CI 1.74–2.22, I²=14.1%), MLR, SII, and PLR; comparable associations were seen for cancer-specific and recurrence-free survival. Each biomarker was analysed in a separate meta-analysis, and the contributing studies differed in design, populations, and cut-off values; the markers were therefore not compared statistically, and no inference regarding their relative prognostic performance is made. Conclusion: Preoperative systemic inflammatory biomarkers are individually associated with oncological outcomes following RNU for UTUC. Because each marker was pooled separately and the studies were clinically heterogeneous, the markers were not compared statistically and no ranking is implied; the findings are descriptive and hypothesis-generating. This meta-analysis of aggregate data did not assess predictive performance (discrimination, calibration, or clinical utility), and any SIRI–NLR combination remains a hypothesis requiring prospective, individual-patient-data validation before any clinical application. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261307425 , identifier CRD420261307425.
- 29 July 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1899751
Open AccessPrognostic performance of preoperative systemic inflammatory biomarkers in upper tract urothelial carcinoma after radical nephroureterectomy: a systematic review and meta-analysis of NLR, MLR, PLR, SII and SIRI
Background: Risk stratification remains challenging in patients with upper tract urothelial carcinoma (UTUC) undergoing radical nephroureterectomy (RNU). Preoperative systemic inflammatory biomarkers may provide prognostic information, but their relative clinical utility remains unclear. Methods: This systematic review and meta-analysis evaluated five commonly used preoperative inflammatory biomarkers—neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI)—in patients with UTUC treated with RNU. PubMed, Embase, Web of Science, and Cochrane Library were searched up to March 2026. Multivariate hazard ratios (HRs) for overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) were pooled using random-effects models. Evidence certainty was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Results: Twelve retrospective studies comprising 7,346 patients were included. Elevated inflammatory biomarker levels were generally associated with worse survival outcomes across available studies. Significant associations with overall survival were observed for SIRI (pooled HR 2.09, 95% CI 1.27–3.44), NLR (pooled HR 1.97, 95% CI 1.74–2.22, I²=14.1%), MLR, SII, and PLR; comparable associations were seen for cancer-specific and recurrence-free survival. Each biomarker was analysed in a separate meta-analysis, and the contributing studies differed in design, populations, and cut-off values; the markers were therefore not compared statistically, and no inference regarding their relative prognostic performance is made. Conclusion: Preoperative systemic inflammatory biomarkers are individually associated with oncological outcomes following RNU for UTUC. Because each marker was pooled separately and the studies were clinically heterogeneous, the markers were not compared statistically and no ranking is implied; the findings are descriptive and hypothesis-generating. This meta-analysis of aggregate data did not assess predictive performance (discrimination, calibration, or clinical utility), and any SIRI–NLR combination remains a hypothesis requiring prospective, individual-patient-data validation before any clinical application. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261307425 , identifier CRD420261307425.
- 6 May 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (5) , 105993
The role of the external genitalia score (EGS) in evaluation of disorders of sex development
- 6 May 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (5) , 105993
The role of the external genitalia score (EGS) in evaluation of disorders of sex development
- Open Access
- 9 November 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1236167
Prognostic value of preoperative albumin-to-alkaline phosphatase ratio in patients with surgically treated urological cancer: a systematic review and meta-analysis
Objective: A novel albumin-to-alkaline phosphatase ratio (AAPR) is associated with the prognosis of several cancers. In the present study, we evaluate the prognostic significance of perioperative AAPR in urological cancers.Method: Relevant studies were searched comprehensively from CNKI, PubMed, Embase and Web of Science up to March 2023. The pooled hazard ratio (HR) and 95% confidence interval (CI) were extracted from each study to evaluate the prognostic value of perioperative AAPR in patients with surgically treated urological cancers.Results: A total of 8 studies consisting of 3,271 patients were included in the final results. A low AAPR was significantly associated with a worse OS (HR=2.21; P<0.001), CSS (HR=2.61; P<0.001) and RFS/DFS (HR=2.87; P=0.001). Stratified by disease, a low AAPR was also associated with worse OS in renal cell carcinoma (HR=2.01; P<0.001), bladder cancer (HR=3.37; P<0.001) and upper tract urothelial carcinoma (HR=1.59; P=0.002).Conclusion: In conclusion, low AAPR could serve as an unfavorable factor in patients with surgically treated urological cancers. Stratified by tumor type, the low AAPR was also associated with inferior survival. While more prospective and large-scale studies are warranted to validate our findings.
- 9 November 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1236167
Open AccessPrognostic value of preoperative albumin-to-alkaline phosphatase ratio in patients with surgically treated urological cancer: a systematic review and meta-analysis
Objective: A novel albumin-to-alkaline phosphatase ratio (AAPR) is associated with the prognosis of several cancers. In the present study, we evaluate the prognostic significance of perioperative AAPR in urological cancers.Method: Relevant studies were searched comprehensively from CNKI, PubMed, Embase and Web of Science up to March 2023. The pooled hazard ratio (HR) and 95% confidence interval (CI) were extracted from each study to evaluate the prognostic value of perioperative AAPR in patients with surgically treated urological cancers.Results: A total of 8 studies consisting of 3,271 patients were included in the final results. A low AAPR was significantly associated with a worse OS (HR=2.21; P<0.001), CSS (HR=2.61; P<0.001) and RFS/DFS (HR=2.87; P=0.001). Stratified by disease, a low AAPR was also associated with worse OS in renal cell carcinoma (HR=2.01; P<0.001), bladder cancer (HR=3.37; P<0.001) and upper tract urothelial carcinoma (HR=1.59; P=0.002).Conclusion: In conclusion, low AAPR could serve as an unfavorable factor in patients with surgically treated urological cancers. Stratified by tumor type, the low AAPR was also associated with inferior survival. While more prospective and large-scale studies are warranted to validate our findings.
- Open Access
- 1 November 2022
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 11 (11) , 1577-1585
Analysis of factors associated with postoperative complications after primary hypospadias repair: a retrospective study
Original Article Analysis of factors associated with postoperative complications after primary hypospadias repair: a retrospective study Zirong He, Bo Yang, Yunman Tang, Yu Mao
- 1 November 2022
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 11 (11) , 1577-1585
Open AccessAnalysis of factors associated with postoperative complications after primary hypospadias repair: a retrospective study
Original Article Analysis of factors associated with postoperative complications after primary hypospadias repair: a retrospective study Zirong He, Bo Yang, Yunman Tang, Yu Mao
- Open Access
- 14 May 2021
- Published by MDPI AG in European Burn Journal
- Vol. 2 (2) , 41-54
Corticosteroid Injection Alone or Combined with Surgical Excision of Keloids versus Other Therapies Including Ionising Radiotherapy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Keloid scars are difficult to manage and remain a therapeutic challenge. Corticosteroid therapy alone or ionising radiation (radiotherapy) alone or combined with surgery are first-line treatments, but the scientific justification for these treatments is unclear. The aim of this systematic review and meta-analysis of randomised controlled trials (RCTs) is to assess the effects of intralesional corticosteroid injection in treating keloids or preventing their recurrence after surgical removal. Searches for RCTs were conducted through the MEDLINE, EMBASE, EBSCO and Cochrane databases from January 1974 to September 2017. Two authors independently reviewed study eligibility, extracted data, analysed the results, and assessed methodological quality. Sixteen RCTs that included more than 814 patients were scrutinised. The quality of evidence for most outcomes was moderate to high. In 10 RCTs, corticosteroid intralesional injections were compared with 5-fluorouracil, etanercept, cryosurgery, botulinum toxin, topical corticosteroid under a silicone dressing, and radiotherapy. Corticosteroid intralesional injections were more effective than radiotherapy (RR 3.3, 95% CI: 1.4–8.1) but equipotent with the other interventions. In conjunction with keloid excision, corticosteroid treatment was compared with radiotherapy, interferon α-2b and verapamil. In two RCTs, there were fewer keloid recurrences (RR 0.43, 95% CI: 0.21–0.89) demonstrated with adjuvant radiotherapy than with corticosteroid injections. More high-quality, large-scale RCTs are required to establish the effectiveness of corticosteroids and other therapies in keloid management.
- 14 May 2021
- Published by MDPI AG in European Burn Journal
- Vol. 2 (2) , 41-54
Open AccessCorticosteroid Injection Alone or Combined with Surgical Excision of Keloids versus Other Therapies Including Ionising Radiotherapy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Keloid scars are difficult to manage and remain a therapeutic challenge. Corticosteroid therapy alone or ionising radiation (radiotherapy) alone or combined with surgery are first-line treatments, but the scientific justification for these treatments is unclear. The aim of this systematic review and meta-analysis of randomised controlled trials (RCTs) is to assess the effects of intralesional corticosteroid injection in treating keloids or preventing their recurrence after surgical removal. Searches for RCTs were conducted through the MEDLINE, EMBASE, EBSCO and Cochrane databases from January 1974 to September 2017. Two authors independently reviewed study eligibility, extracted data, analysed the results, and assessed methodological quality. Sixteen RCTs that included more than 814 patients were scrutinised. The quality of evidence for most outcomes was moderate to high. In 10 RCTs, corticosteroid intralesional injections were compared with 5-fluorouracil, etanercept, cryosurgery, botulinum toxin, topical corticosteroid under a silicone dressing, and radiotherapy. Corticosteroid intralesional injections were more effective than radiotherapy (RR 3.3, 95% CI: 1.4–8.1) but equipotent with the other interventions. In conjunction with keloid excision, corticosteroid treatment was compared with radiotherapy, interferon α-2b and verapamil. In two RCTs, there were fewer keloid recurrences (RR 0.43, 95% CI: 0.21–0.89) demonstrated with adjuvant radiotherapy than with corticosteroid injections. More high-quality, large-scale RCTs are required to establish the effectiveness of corticosteroids and other therapies in keloid management.
- Open Access
- 28 March 2017
- Published by Springer Nature in BMC Urology
- Vol. 17 (1) , 21
Evaluation and treatment for ovotesticular disorder of sex development (OT-DSD) - experience based on a Chinese series
The aim of this study is to review and present the clinical features and process of evaluation and treatment for OT-DSD in a single center in recent years in China. Sixteen patients with OT-DSD during the past 4 years underwent the evaluation and treatment in a single center. The clinical characteristics and outcomes of surgery were analyzed. The surgical age ranged from 17 months to 66 months with a mean age of 20 months, and the mean follow-up was 30 months (4 months to 56 months). The presentation in 11 patients was ambiguous genitalia, and the rest 5 patients were suspected to have DSD in preoperative examination before hypospadias repair. The karyotypes were 46, XX in 11 patients, 46, XX/46, XY in 3, 46, XX/47, XXY in 1, and 46, XY in 1. Initial reared sex was male in 14 patients, female in 1, and undetermined in 1. After surgery, genders were reassigned in 3 patients, while 15 patients were raised as male with testicular tissue left. Only 1 patient with ovarian tissue left was raised as female. Repair was completed in 11 males and 1 female, and stage I urethroplasty was done in 4 males. No further surgery to remove the gonads was needed for inconsonance of gender assignment. No gonadal tumors were detected. OT-DSD is a rare and complex deformity with few systematic reports in China. It’s important to establish a regular algorithm for evaluation and treatment of OT-DSD.
- 28 March 2017
- Published by Springer Nature in BMC Urology
- Vol. 17 (1) , 21
Open AccessEvaluation and treatment for ovotesticular disorder of sex development (OT-DSD) - experience based on a Chinese series
The aim of this study is to review and present the clinical features and process of evaluation and treatment for OT-DSD in a single center in recent years in China. Sixteen patients with OT-DSD during the past 4 years underwent the evaluation and treatment in a single center. The clinical characteristics and outcomes of surgery were analyzed. The surgical age ranged from 17 months to 66 months with a mean age of 20 months, and the mean follow-up was 30 months (4 months to 56 months). The presentation in 11 patients was ambiguous genitalia, and the rest 5 patients were suspected to have DSD in preoperative examination before hypospadias repair. The karyotypes were 46, XX in 11 patients, 46, XX/46, XY in 3, 46, XX/47, XXY in 1, and 46, XY in 1. Initial reared sex was male in 14 patients, female in 1, and undetermined in 1. After surgery, genders were reassigned in 3 patients, while 15 patients were raised as male with testicular tissue left. Only 1 patient with ovarian tissue left was raised as female. Repair was completed in 11 males and 1 female, and stage I urethroplasty was done in 4 males. No further surgery to remove the gonads was needed for inconsonance of gender assignment. No gonadal tumors were detected. OT-DSD is a rare and complex deformity with few systematic reports in China. It’s important to establish a regular algorithm for evaluation and treatment of OT-DSD.